SENSICARDIAC vs Rapid RV/LV

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC

by DIACOUSTIC MEDICAL (PTY)

Rapid RV/LV

by RapidAI (formerly iSchemaView)

AI Verdict

SENSICARDIAC is an AI-powered, cloud-based service for detecting and classifying heart murmurs using electronic stethoscope data, aimed at aiding diagnosis and reducing unnecessary referrals. Rapid RV/LV, on the other hand, is an FDA-cleared AI tool that analyzes CTPA scans to rapidly assess pulmonary embolism severity by measuring right and and left ventricle ratios. While both are cardiology AI solutions, they address different diagnostic modalities and specific clinical conditions, making them adjacent rather than direct competitors.

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your practice requires an AI-powered, cloud-based solution for real-time heart murmur detection during patient auscultation, especially in telehealth or primary care settings. This tool is ideal for physicians aiming to quickly classify murmurs as pathological or physiological, thereby reducing unnecessary specialist referrals and enhancing early diagnostic accuracy.

View SENSICARDIAC →

Choose Rapid RV/LV if…

Choose Rapid RV/LV if your facility needs an FDA-cleared AI tool for the rapid and automated assessment of pulmonary embolism severity directly from CTPA scans. This solution is best suited for emergency departments and radiology departments where quick, consistent measurement of right and left ventricle ratios is crucial for timely patient triage and management.

View Rapid RV/LV →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC	Rapid RV/LV
Pricing	Contact for pricing	Contact vendor for pricing information.
Deployment	Cloud, Desktop (Windows)	On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall.
BAA Available	Yes AI-estimated	Unknown
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC

SENSICARDIAC offers a more direct and interactive user experience for clinicians with its guided auscultation process and real-time feedback at the point of care. Rapid RV/LV, while efficient in its automation, primarily functions as a background image processing tool, with user interaction focused on reviewing automated results rather than a real-time guided process.

Clinical Value

Tie

Both tools are FDA-cleared and provide significant clinical value in their respective domains. SENSICARDIAC aids in early diagnosis and reduces unnecessary referrals for heart murmurs, while Rapid RV/LV offers rapid, objective assessment for a critical condition like pulmonary embolism, reducing inter-rater variability in a time-sensitive setting.

Pricing & Value

Tie

Both tools require direct vendor contact for pricing information, making it impossible to compare their cost-effectiveness or value proposition without further details. Neither provides public pricing transparency.

Enterprise Readiness

Rapid RV/LV

Rapid RV/LV offers flexible on-premises or hybrid deployment options, which can be crucial for large healthcare systems with specific IT infrastructure and data security requirements. Its integration with the broader Rapid platform, including triage and notification capabilities, suggests a more comprehensive enterprise solution for workflow integration.

Innovation

SENSICARDIAC

SENSICARDIAC's innovative approach lies in bringing AI directly to the point of care, augmenting a traditionally subjective physical examination with real-time, guided auscultation and analysis. While Rapid RV/LV is also innovative in automating critical image analysis, SENSICARDIAC's application directly within the physical exam workflow represents a more novel integration of AI.

Support & Docs

Rapid RV/LV

RapidAI demonstrates a significantly more robust and comprehensive support and documentation infrastructure, including 24/7/365 multilingual customer support via email and phone, extensive online resources, and a dedicated training program ('Rapid U'). SENSICARDIAC's publicly available information on support is comparatively limited, primarily referencing a user manual and white papers on request.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC	Rapid RV/LV
Name	SENSICARDIAC	Rapid RV/LV
Company	DIACOUSTIC MEDICAL (PTY)	RapidAI (formerly iSchemaView)
Primary Function	AI-powered, cloud-based heart murmur detection service that classifies murmurs as pathological or physiological.	AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.
Data Input	Electronic stethoscopes (e.g., 3M Littmannu00ae 3200)	CTPA images
Key Output/Results	Classification of murmurs (Class I: dangerous pathological, Class III: innocent physiological), detailed cardiac reports (downloadable PDFs, visualization, S1/S2 indicators).	Automated measurement of right and left ventricle diameters, calculation of RV/LV ratio, annotated images showing ventricular measurements.
Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC and Rapid RV/LV.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do SENSICARDIAC's real-time auscultation analysis and Rapid RV/LV's automated CTPA measurements specifically integrate into and improve existing clinical workflows for their respective conditions?

SENSICARDIAC is designed to provide real-time murmur classification during auscultation with an electronic stethoscope, aiming to streamline cardiac screening and potentially reduce unnecessary referrals by aiding in immediate diagnostic decisions. Rapid RV/LV integrates into the acute pulmonary embolism (PE) diagnostic pathway by rapidly providing automated right ventricle to left ventricle (RV/LV) ratio calculations from CTPA scans, which helps physicians quickly assess PE severity and risk stratify patients with right heart strain for faster treatment.

What is the depth of EHR integration for each tool beyond basic report generation, specifically regarding automated data transfer and accessibility of AI-derived insights within patient records?

SENSICARDIAC generates detailed cardiac reports as downloadable PDFs, which may require manual upload or a more advanced integration for direct EHR population. Rapid RV/LV, as part of the broader Rapid PE solution, offers integration with imaging systems and can provide triage and notification capabilities, suggesting a deeper level of automated data transfer and accessibility of its AI-derived RV/LV ratios within patient records.

What specific clinical validation studies or performance metrics are available to demonstrate the accuracy and sensitivity of SENSICARDIAC in classifying heart murmurs and Rapid RV/LV in calculating RV/LV ratios?

SENSICARDIAC analyzes heart sound recordings against a large validated database of pathological heart murmurs for classification, implying internal validation. Rapid RV/LV is FDA-cleared and uses AI to automatically calculate RV/LV ratios from CTPA scans within minutes, which has been shown to reduce inter-rater variability and aid in risk stratification for PE patients.

Considering the distinct user interfaces and functionalities, what is the expected learning curve for physicians in their respective specialties to become proficient in using each AI tool and interpreting its output?

SENSICARDIAC features a guided auscultation process and real-time analysis, suggesting a relatively intuitive learning curve for physicians using electronic stethoscopes for murmur detection. Rapid RV/LV's automated analysis of CTPA images and annotated ventricular measurements aim to simplify the interpretation of complex imaging data, likely leading to a quick learning curve for radiologists, cardiologists, and pulmonologists in assessing PE severity.

What audit-trail capabilities do SENSICARDIAC and Rapid RV/LV offer to track AI analysis, user interactions, and report generation for quality assurance and accountability purposes?

SENSICARDIAC generates detailed cardiac reports that serve as a record of the AI's output for a patient encounter. Rapid RV/LV, as part of a broader platform, likely offers audit-trail features to track AI analysis, user interactions, and notifications related to PE severity assessment, which are crucial for compliance and quality assurance in medical imaging.

For healthcare systems operating across multiple sites, what are the primary considerations for deploying and scaling each tool, particularly regarding infrastructure requirements, data synchronization, and user management?

SENSICARDIAC's cloud-based nature simplifies multi-site deployment, primarily requiring internet access and compatible electronic stethoscopes at each location for scalability. Rapid RV/LV's on-premises or hybrid deployment necessitates careful planning for server infrastructure, secure network links, and consistent data synchronization across sites, along with robust user management for access to imaging data.